← Back to catalogue

Panoscreen I, II, and III

FDA UDI

by Immucor, Inc.

Identity

Trade Name
Panoscreen I, II, and III FDA UDI
Generic Name
Antibody screening reagent red blood cell IVD, kit, agglutination FDA UDI
Device Name
Panoscreen I, II, and III is intended for use in the detection of unexpected IgG antibodies to red blood cells by manual tube method. The configuration of this product is a 3-cell screen. FDA UDI
Model / Reference
0002381 FDA UDI
Description
Panoscreen I, II, and III is intended for use in the detection of unexpected IgG antibodies to red blood cells by manual tube method. The configuration of this product is a 3-cell screen. FDA UDI

Identifiers

Catalog Number
0002381 FDA UDI
Primary DI / UDI-DI
10888234000303 FDA UDI
GMDN Term
Antibody screening reagent red blood cell IVD, kit, agglutination FDA UDI

Classification

Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

Yes

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Antibody screening reagent red blood cell IVD, kit, agglutination

Panoscreen I, II, and III by Immucor, Inc. — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Antibody screening reagent red blood cell IVD, kit, agglutination.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Immucor, Inc.

Sources (1)

  • FDA UDI 9784b8e1-a18b-45a6-b033-8002479699eb 35 fields · synced May 29, 2026